Courtney E. Maus, Ph.D.
Affiliations: | 2005 | Emory University, Atlanta, GA |
Area:
Microbiology Biology, Genetics, Public HealthGoogle:
"Courtney Maus"Cross-listing: PHTree
Parents
Sign in to add mentor| Thomas M. Shinnick | grad student | 2005 | Emory | |
| (Capreomycin resistance in Mycobacterium tuberculosis: Identification the molecular mechanism of resistance and characterization of cross-resistance to ribosome -inhibiting drugs.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shah M, Paradis S, Betz J, et al. (2019) Multicenter Study of the Accuracy of the BD MAX™ MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Murray P, Cooper C, Maus C. (2019) Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays. Journal of Clinical Microbiology. 57 |
| Johansen SK, Maus CE, Plikaytis BB, et al. (2006) Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2'-O-methylations in 16S and 23S rRNAs. Molecular Cell. 23: 173-82 |
| Maus CE, Plikaytis BB, Shinnick TM. (2005) Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 49: 3192-7 |
| Maus CE, Plikaytis BB, Shinnick TM. (2005) Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 49: 571-7 |